期刊文献+

白介素-17A对恢复期病毒性心肌炎小鼠抗ANT抗体的影响

THE EFFECT OF IL-17A ON ANTI-ADENINE NUCLEOTIDE TRANSLOCATOR(ANT)AUTOANTIBODIES IN MICE WITH VIRAL MYOCARDITIS AT RECOVERY STAGES
下载PDF
导出
摘要 目的:观察白介素-17A(IL-17A)对恢复期病毒性心肌炎小鼠血清抗线粒体内膜ADP/ATP载体自身抗体(抗ANT抗体)水平的影响。方法:IL-17A敲除型(IL-17A-/-)以及野生型(WT)Balb/c小鼠腹腔注射含柯萨奇病毒B3(CVB3)的磷酸盐缓冲溶液(PBS)建立病毒性心肌炎小鼠模型(VMC-IL-17A-/-组和VMC-WT组),WT Balb/c小鼠腹腔注射PBS作为健康-WT组,注射病毒液或PBS后第42天留取血清,ELISA法测定血清中抗ANT抗体水平;取心肌组织作石蜡切片,HE染色观察心肌组织病理改变。结果:与健康-WT组相比,VMC-WT组小鼠血清中抗ANT抗体水平显著升高,差异有统计学意义(P<0.05);而与VMC-WT组相比,VMC-IL-17A-/-组小鼠血清中抗ANT抗体水平明显降低,差异有统计学意义(P<0.05)。结论:IL-17A促进恢复期VMC小鼠血清抗ANT抗体的产生。 Objective:To explore the effect of interleukins-17A(IL-17A)on the level of anti-adenine nucleotide translocator(ANT)autoantibodies in mice with viral myocarditis(VMC)at the recovery stage.Methods:Male wild-type(WT)and IL-17A-deficient(IL-17A-/-)Balb/c mice were intraperitoneally(i.p)injected with coxsackie virus B3(CVB3)to establish VMC models(VMC-WT group and VMC-IL-17A-/-group).Meanwhile,a control group(WT group)of WT mice were established and treated with phosphate buffered saline i.p.Paraffin sections of cardiac tissues were prepared 42 days after CVB3 injection.Myocardial histopathologic changes were evaluated by hematoxylin-eosin staining.The level of anti-ANT autoantibodies was measured by enzyme-linked immunosorbent assay(ELISA).Results:Compared with WT group,the level of anti-ANT autoantibodies was significantly increased in VMC-WT group(P〈0.05).Compared with VMC-WT group,the level of anti-ANT autoantibodies was reduced in VMC-IL-17A-/-group(P〈0.05).Conclusion:IL-17 Acontributes to the secretion of anti-ANT autoantibodies of VMC mice at the recovery stage.
作者 刘畅 伍伟锋 孔清 岑治宏 Liu Chang Wu Weifeng Kong Qing Cen Zhihong(Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China)
出处 《广西医科大学学报》 CAS 2016年第3期394-396,共3页 Journal of Guangxi Medical University
基金 国家自然科学基金资助项目(No.81260045)
关键词 病毒性心肌炎 白介素-17A 扩张型心肌病 viral myocarditis IL-17A dilated cardiomyopathy
  • 相关文献

参考文献7

二级参考文献102

  • 1张召才,杨英珍,陈瑞珍,程蕾蕾,葛均波,陈灏珠.病毒性心脏病小鼠心脏胶原代谢的动态变化[J].中国病理生理杂志,2006,22(8):1529-1534. 被引量:11
  • 2肖华,廖玉华,王敏,陈志坚,刘坤,郭和平.扩张型心肌病新型抗钙通道抗体的发现[J].临床心血管病杂志,2007,23(8):601-605. 被引量:7
  • 3LIU P P, MASSON J W. Advances in the understanding of myocarditis [ J ]. Circulation, 2001, 104 (9) : 1076-1082.
  • 4HEYMANS S, PAUSCHINGER M, D E PALMA A, et al. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis [ J ]. Circulation, 2006, 114 (6) : 565- 573.
  • 5IVANOV S, LINDN A. Interleukin-17 as a drug target in human disease[J]. Trends Pharmacol Sci, 2009, 30(2): 95- 103.
  • 6MI S, LI Z, YANG H Z, et al, Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF- betal-dependent and -independent mechanisms [J].J Immunol, 2011, 187(6) : 3003-3014.
  • 7FENG W, LI W, LU W, et al. IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure[J].Exp Mol Pathol, 2009, 87(3) : 212-218.
  • 8FAN Y, WEIFENG W, YULUAN Y, et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammation[J]. Virol J, 2011, 8(1) : 17.
  • 9NAKAE S, KOMIYAMA Y, NAMBU A, et al. Antigen-specific T "cell sensitization is impaired in IL-17-deficient mice,causing suppression of allergic cellular and humoral responses[J]. Immunity, 2002, 17(3) : 375-387.
  • 10QUEREJETA R, VARO N, LOPEZ B, et al. Serum carboxy- terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease [J]. Circulation, 2000, 101 (14) : 1729-1735.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部